Search Results

Collaboration Corner

2019 National Sales Meeting

TissueTech Template Portal

TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]

TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]

Clinical Evidence Presented at SAWC on Application of AMNIOX Medical Products

Four Posters Demonstrate the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC MIAMI, FL – May 8, 2018 – AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted four clinical posters demonstrating the effectiveness of NEOX® Wound Allograft at the Symposium on Advanced Wound Care (SAWC) in April. The presentations illustrate applications of NEOX […]

Sitemap

2016

250,000 applications of the Company’s products

2015

Series B funding – $15M

2013

Series A Funding – $10M